Far-Red Light Activatable, Multifunctional Prodrug for Fluorescence Optical Imaging and Combinational Treatment

Por Bio, Moses, Rajaputra, Pallavi, Nkepang, Gregory, You, Youngjae
Publicado em 2014

Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method

Por Raghuvanshi, Dhawal, Nkepang, Gregory, Hussain, Alamdar, Yari, Hooman, Awasthi, Vibhudutta
Publicado no J Pharm Anal (2017)

Folate Receptor-Mediated Enhanced and Specific Delivery of Far-Red Light-Activatable Prodrugs of Combretastatin A-4 to FR-Positive Tumor

Por Nkepang, Gregory, Bio, Moses, Rajaputra, Pallavi, Awuah, Samuel G., You, Youngjae
Publicado no Bioconjug Chem (2014)

Anticancer Drug Released from Near IR-activated Prodrug Overcomes Spatiotemporal Limits of Singlet Oxygen

Por Rajaputra, Pallavi, Bio, Moses, Nkepang, Gregory, Thapa, Pritam, Woo, Sukyung, You, Youngjae
Publicado no Bioorg Med Chem (2016)

Visible Light Controlled Release of Anticancer Drug through Double Activation of Prodrug

Por Hossion, Abugafar M. L., Bio, Moses, Nkepang, Gregory, Awuah, Samuel G., You, Youngjae
Publicado em 2012

Far-red Light-activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-specific Paclitaxel Chemotherapy

Por Thapa, Pritam, Li, Mengjie, Bio, Moses, Rajaputra, Pallavi, Nkepang, Gregory, Sun, Yajing, Woo, Sukyung, You, Youngjae
Publicado no J Med Chem (2016)

Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells

Por Thapa, Pritam, Li, Mengjie, Karki, Radha, Bio, Moses, Rajaputra, Pallavi, Nkepang, Gregory, Woo, Sukyung, You, Youngjae
Publicado no ACS Omega (2017)